Trials / Completed
CompletedNCT00544895
Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)
Conditions
Timeline
- Start date
- 2007-10-01
- Completion
- 2010-10-01
- First posted
- 2007-10-16
- Last updated
- 2011-06-23
Locations
12 sites across 7 countries: Austria, France, Germany, Italy, Netherlands, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT00544895. Inclusion in this directory is not an endorsement.